6 Hrs
Source:
الشروق التونسية
FDA approves MRTP for 20 ZYN pouches
The U.S. Food and Drug Administration has issued a Modified Risk Tobacco Product (MRTP) authorization for twenty types of ZYN nicotine pouches. This is the first time the agency has granted such approval for non-combustible tobacco products. The authorization allows Philip Morris to clarify that replacing cigarettes with ZYN pouches reduces the risks of smoking-related diseases, such as heart disease, cancer, lung cancer, and stroke, in accordance with specified conditions. This decision is part of the company's efforts to build a smoke-free future, as ZYN is considered an alternative that reduces exposure to harmful substances associated with smoking, helping to decrease addiction and improve the overall health of adult smokers.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)